Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analyst Recommendations on MODERNA, INC.
12:28aWALL STREET WEEK AHEAD : After blazing energy rally, investors check the fuel ga..
RE
12/02Pfizer and BioNTech's Covid-19 Vaccine Wins U.K. Authorization -- 7th Update
DJ
12/02UK approves Pfizer-BioNTech COVID-19 vaccine in world first
RE
11/30MODERNA : Moody's says most sovereigns face 'significant negative shock' from CO..
RE
11/26ASTRAZENECA : Vaccine is no shot in the arm yet for emerging markets
RE
11/24AstraZeneca Gears Up to Vaccinate the World Against Covid-19
DJ
11/23AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials..
DJ
11/23European shares slip as jump in virus cases offsets vaccine hopes
RE
11/20PFIZER, GILEAD, ROSS : What to Watch When the Stock Market Opens Today
DJ
11/18Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authoriza..
DJ
11/18Pfizer's Covid-19 Vaccine 95% Effective in Final Results, Company to Seek App..
DJ
11/18MODERNA : Rate cut bets melt as vaccines boost economy hopes
RE
11/17China stocks slip as healthcare shares, bond defaults weigh
RE
11/05ASTRAZENECA : COVID vaccine deliveries on ice as AstraZeneca awaits trial data
RE
11/05ASTRAZENECA : COVID vaccine deliveries on ice as AstraZeneca awaits trial data
RE
08/21Top FDA official says would resign if agency rubber-stamps an unproven COVID-..
RE
08/20Top FDA official says would resign if agency rubber-stamps an unproven COVID-..
RE
08/12ASTRAZENECA : Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vac..
RE
07/29MODERNA : Receives a Buy rating from Goldman Sachs
MD
07/27MODERNA : Goldman Sachs keeps its Buy rating
MD
07/21Pharma Companies Split on Coronavirus Vaccine Pricing Plans
DJ
02/05Drugmakers see long road ahead in coronavirus vaccine race
RE
Official Publications
09/04Report 
09/03Report 
09/01Report 
08/28Report 
08/26Report 
08/21Report 
Upcoming event on MODERNA, INC.